Showing results (481-490 of 3,371) with videos related to
Sort By:
Pageof 338
Diagnostic Microbiology and Infectious Disease|March 1, 1995
National survey of the in vitro spectrum of piperacillin-tazobactam tested against more than 40,000 aerobic clinical isolates from 236 medical centersE J Baron, R N JonesAntimicrobial Agents and Chemotherapy|July 1, 1995
In vitro evaluation of DV-7751a, a new fluoroquinolone with an enhanced spectrum of activity against gram-positive aerobic organisms and anaerobesD J Biedenbach, R N JonesEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 1, 1993
Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugsH S Sader, R N JonesDiagnostic Microbiology and Infectious Disease|April 29, 1998
Timed kill kinetic studies of levofloxacin, ofloxacin, and ciprofloxacin against Moraxella catarrhalisM S Barrett, R N JonesAmerican Journal of Clinical Pathology|October 1, 1982
Interlaboratory performance of disk agar diffusion and dilution antimicrobial susceptibility tests, 1979-1981. A summary of the microbiology portion of the College of American Pathologists (CAP) surveysR N Jones, D C EdsonJournal of Clinical Microbiology|December 1, 1991
Disk diffusion susceptibility test interpretive criteria for GR69153, a new catechol-substituted cephalosporinR N Jones, M E ErwinPostgraduate Medicine|August 12, 2009
Global view of antimicrobial resistance. Findings of the SENTRY Antimicrobial Surveillance Program, 1997-1999M A Pfaller, R N JonesBurns : Journal of the International Society for Burn Injuries|May 18, 2004
Is high PEEP low volume ventilation in burn patients beneficial? A retrospective study of 61 patientsT P Wolter, P C Fuchs, N Horvat, et al.International Journal of Antimicrobial Agents|May 1, 1996
Susceptibility surveillance of U.S. respiratory pathogen isolates to newer macrolide and azalide antibioticsS Brown, A L Barry, P BurtonJournal of Chemotherapy (Florence, Italy)|March 15, 2002
Antimicrobial resistance in gram-negative isolates from European intensive care units: data from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) programmeJ A Garcia-Rodriguez, R N Jones, Pageof 338